These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23858556)

  • 1. Blood urea nitrogen is elevated in patients with non-alcoholic fatty liver disease.
    Liu X; Zhang H; Liang J
    Hepatogastroenterology; 2013; 60(122):343-5. PubMed ID: 23858556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean platelet volume in patients with non-alcoholic fatty liver disease.
    Ozhan H; Aydin M; Yazici M; Yazgan O; Basar C; Gungor A; Onder E
    Platelets; 2010; 21(1):29-32. PubMed ID: 19947902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
    Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
    Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores.
    Senateş E; Colak Y; Yeşil A; Coşkunpinar E; Sahin O; Kahraman OT; Erkalma Şenateş B; Tuncer I
    Minerva Med; 2012 Oct; 103(5):369-76. PubMed ID: 23042372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
    Shieh K; Gilchrist JM; Promrat K
    Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
    Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
    Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.
    Das KS; Balakrishnan V; Mukherjee S; Vasudevan DM
    Scand J Clin Lab Invest; 2008; 68(4):323-34. PubMed ID: 18609067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease.
    Franzini M; Fornaciari I; Fierabracci V; Elawadi HA; Bolognesi V; Maltinti S; Ricchiuti A; De Bortoli N; Marchi S; Pompella A; Passino C; Emdin M; Paolicchi A
    Liver Int; 2012 Apr; 32(4):629-34. PubMed ID: 22098947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance.
    de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R; Gonzalez JM
    Diabetes Res Clin Pract; 2008 Jan; 79(1):74-8. PubMed ID: 17766001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
    Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
    Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.